Zenas BioPharma (ZBIO) Enterprise Value (2023 - 2026)

Zenas BioPharma's Enterprise Value history runs 4 years deep, the most recent figure standing at -$717.2 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 129.59% year-over-year to -$717.2 million; the TTM figure through Mar 2026 stood at -$717.2 million (down 129.59% YoY), while the FY2025 annual figure was -$343.2 million, up 2.16% from the prior year.
• Enterprise Value was -$717.2 million for Q1 2026 at Zenas BioPharma, down from -$343.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$37.2 million in Q1 2024 to a low of -$717.2 million in Q1 2026.
• Historically, Enterprise Value has averaged -$272.6 million across 4 years, with a median of -$290.9 million in 2025.
• Biggest YoY gain for Enterprise Value was 19.23% in 2025; the steepest drop was 738.83% in 2025.
• A 4-year view of Enterprise Value shows it stood at -$56.9 million in 2023, then tumbled by 516.93% to -$350.8 million in 2024, then advanced by 2.16% to -$343.2 million in 2025, then sank by 108.98% to -$717.2 million in 2026.
• The last three Enterprise Value figures came in at -$717.2 million (Q1 2026), -$343.2 million (Q4 2025), and -$290.9 million (Q3 2025), per Business Quant data.